Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) Return on Equity (2021 - 2025)

Historic Return on Equity for HCW Biologics (HCWB) over the last 5 years, with Q3 2025 value amounting to 11.8%.

  • HCW Biologics' Return on Equity rose 72000.0% to 11.8% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.8%, marking a year-over-year increase of 72000.0%. This contributed to the annual value of 9.0% for FY2024, which is 79800.0% down from last year.
  • According to the latest figures from Q3 2025, HCW Biologics' Return on Equity is 11.8%, which was up 72000.0% from 3.07% recorded in Q2 2025.
  • In the past 5 years, HCW Biologics' Return on Equity ranged from a high of 11.8% in Q3 2025 and a low of 31.73% during Q2 2024
  • Its 5-year average for Return on Equity is 0.79%, with a median of 0.28% in 2022.
  • In the last 5 years, HCW Biologics' Return on Equity tumbled by -310900bps in 2024 and then skyrocketed by 348100bps in 2025.
  • Over the past 5 years, HCW Biologics' Return on Equity (Quarter) stood at 0.25% in 2021, then plummeted by -50bps to 0.38% in 2022, then plummeted by -266bps to 1.39% in 2023, then surged by 358bps to 3.6% in 2024, then soared by 228bps to 11.8% in 2025.
  • Its last three reported values are 11.8% in Q3 2025, 3.07% for Q2 2025, and 3.24% during Q1 2025.